https://pubmed.ncbi.nlm.nih.gov/39739385/
The 2024 EULAR points to consider provide guidance on the management of targeted therapies in patients with IA and a previous malignancy.
on theeularpointsconsiderinitiation
https://www.surveymonkey.com/r/BIRDEULARBSRbursaryapplication
Take this survey powered by surveymonkey.com. Create your own surveys for free.
available forbursariesbsraprileular
https://www.sanofi.com/fr/media-room/communiques-de-presse/2025/2025-06-12-08-30-00-3098093
EULAR: rilzabrutinib data in IgG4-related disease show reduction in flares and key disease markers; earns Fast Track designation in the US New rilzabrutinib...
mediaupdateeularrilzabrutinibdata